Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated

Luka Nicin1,2,3, Wesley T Abplanalp1,2,3, Anne Schänzer4

  • 1Institute for Cardiovascular Regeneration (L.N., W.T.A., D.J., H.M., L.T., S.D.), Goethe University, Germany.

Circulation
|February 23, 2021
PubMed

Insights

Pediatric dilated cardiomyopathy (DCM) shows age-dependent cellular changes. Infants with DCM have proregenerative heart cells, while older children exhibit increased fibrosis and activated fibroblasts.

Area of Science:

  • Cardiovascular Biology
  • Pediatric Cardiology
  • Molecular Genetics

Background:

  • Dilated cardiomyopathy (DCM) is a primary cause of pediatric heart failure with variable treatment outcomes.
  • Lack of large cohort studies hinders progress in pediatric heart failure management.
  • Personalized therapy considering age- and disease-specific factors is crucial for improving outcomes.

Purpose of the Study:

  • To identify cellular signatures in pediatric DCM using single nuclei RNA sequencing.
  • To investigate age-dependent molecular and cellular alterations in pediatric DCM hearts.

Main Methods:

  • Single nuclei RNA sequencing was performed on heart tissues from six pediatric DCM patients (ages 0.5-13 years).
  • Unsupervised clustering identified 14 distinct cell clusters, representing 6 major cell types.
  • Histological analysis and cardiac magnetic resonance imaging (MRI) were used for validation.

Main Results:

  • Fibroblast populations increased with age in DCM patients, correlating with cardiac fibrosis.
  • Fibroblasts in older DCM patients (>6 years) displayed altered gene expression, including collagen and proteoglycan modulation.
  • Infants with DCM possessed a proregenerative cardiomyocyte population, absent in older children, with high expression of cell cycle and metabolic genes.

Conclusions:

  • Pediatric DCM exhibits significant age-dependent changes in fibroblast and cardiomyocyte gene expression.
  • Infants with DCM show less fibrosis and more proregenerative cellular signatures compared to older children.
  • These findings offer novel insights into DCM pathophysiology and potential therapeutic targets.
Abstract